Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Nov;63(11):1636–1641. doi: 10.2967/jnumed.122.264373

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

PMC Copyright notice

FIGURE 3. — Dramatic improvement in a patient refractory to anti–PD-L1 (avelumab) receiving a single off-label dose of ¹⁷⁷Lu-DOTATATE for heavily metastatic MCC and resuming avelumab. (A) Pretreatment ⁶⁸Ga-DOTATATE PET/CT scan. (B) ¹⁷⁷Lu-DOTATATE SPECT/CT scan during TRT. (C) ⁶⁸Ga-DOTATATE PET/CT scan 1 mo after treatment. (Reprinted with permission of ( 44 ).)